Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6268)
All Articles published online
|
Publishing Process of This Article
|
Jun 14, 2014 (publication date) through Dec 31, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Waluga M, Hartleb M, Boryczka G, Kukla M, Żwirska-Korczala K. Serum adipokines in inflammatory bowel disease. World J Gastroenterol 2014; 20(22): 6912-6917 [PMID: 24944482 DOI: 10.3748/wjg.v20.i22.6912] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i22/6912.htm |
| Number | Citing Articles |
| 1 |
Diogo Magalhaes, Laurent Peyrin-Biroulet, Maria Manuela Estevinho, Silvio Danese, Fernando Magro. Pursuing neutrophils: systematic scoping review on blood-based biomarkers as predictors of treatment outcomes in inflammatory bowel disease. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231155987
|
| 2 |
Jack Hutcheson. Adipokines influence the inflammatory balance in autoimmunity. Cytokine 2015; 75(2): 272 doi: 10.1016/j.cyto.2015.04.004
|
| 3 |
Md. Murad Hossain, Abdul Mukheem, Tunku Kamarul. The prevention and treatment of hypoadiponectinemia-associated human diseases by up-regulation of plasma adiponectin. Life Sciences 2015; 135: 55 doi: 10.1016/j.lfs.2015.03.010
|
| 4 |
Sotirios Terzoudis, Niki Malliaraki, John Damilakis, Daphne A. Dimitriadou, Christos Zavos, Ioannis E. Koutroubakis. Chemerin, visfatin, and vaspin serum levels in relation to bone mineral density in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(7): 814 doi: 10.1097/MEG.0000000000000617
|
| 5 |
Fabiola Trejo‑Vazquez, Idalia Garza‑Veloz, Gabriela Villela‑Ramirez, Yolanda Ortiz‑Castro, Panfilo Mauricio‑Saucedo, Edith Cardenas‑Vargas, Mariana Diaz‑Baez, Miguel Cid‑Baez, Rodrigo Casta�eda‑Miranda, Jose Ortiz‑Rodriguez, Luis Solis‑Sanchez, Margarita Martinez‑Fierro. Positive association between leptin serum levels and disease activity on endoscopy in inflammatory bowel disease: A case-control study. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5835
|
| 6 |
Marcin Sochal, Paula Mosińska, Jakub Fichna. Diagnostic value of chemerin in lower gastrointestinal diseases—a review. Peptides 2018; 108: 19 doi: 10.1016/j.peptides.2018.08.012
|
| 7 |
Chang-Kee Hyun. Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2021; 22(17): 9139 doi: 10.3390/ijms22179139
|
| 8 |
Michael Camilleri, Harmeet Malhi, Andres Acosta. Gastrointestinal Complications of Obesity. Gastroenterology 2017; 152(7): 1656 doi: 10.1053/j.gastro.2016.12.052
|
| 9 |
Giorgia Colombo, Nausicaa Clemente, Andrea Zito, Cristiano Bracci, Federico Simone Colombo, Sabina Sangaletti, Elena Jachetti, Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Luca Pastorelli, Marco De Andrea, Samuele Naviglio, Marianna Lucafò, Gabriele Stocco, Ambra A. Grolla, Michela Campolo, Giovanna Casili, Salvatore Cuzzocrea, Emanuela Esposito, Fabio Malavasi, Armando A. Genazzani, Chiara Porta, Cristina Travelli. Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis. Journal of Molecular Medicine 2020; 98(4): 595 doi: 10.1007/s00109-020-01892-0
|
| 10 |
Elena Neumann, Nina Lepper, Massimiliano Vasile, Valeria Riccieri, Marvin Peters, Florian Meier, Marie-Lisa Hülser, Oliver Distler, Steffen Gay, Poornima Mahavadi, Andreas Günther, Elke Roeb, Klaus W. Frommer, Magnus Diller, Ulf Müller-Ladner. Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement. Cytokine 2019; 117: 41 doi: 10.1016/j.cyto.2018.11.013
|
| 11 |
Marcin Sochal, Jakub Fichna, Agata Gabryelska, Renata Talar-Wojnarowska, Piotr Białasiewicz, Ewa Małecka-Wojciesko. Serum Levels of Chemerin in Patients with Inflammatory Bowel Disease as an Indicator of Anti-TNF Treatment Efficacy. Journal of Clinical Medicine 2021; 10(19): 4615 doi: 10.3390/jcm10194615
|
| 12 |
Damian Jacenik, Jakub Fichna. Chemerin in immune response and gastrointestinal pathophysiology. Clinica Chimica Acta 2020; 504: 146 doi: 10.1016/j.cca.2020.02.008
|
| 13 |
Larissa Gabriela Ferreira de Carvalho, William Gustavo Lima, Luiz Gonzaga Vaz Coelho, Valbert Nascimento Cardoso, Simone Odília Antunes Fernandes. Circulating Leptin Levels as a Potential Biomarker in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases 2021; 27(2): 169 doi: 10.1093/ibd/izaa037
|
| 14 |
Roger Suau, Eva Pardina, Eugeni Domènech, Violeta Lorén, Josep Manyé. The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease. Journal of Crohn's and Colitis 2022; 16(3): 472 doi: 10.1093/ecco-jcc/jjab159
|
| 15 |
Teodora Surdea-Blaga, Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Abdalla Elsayed, Mohamed Ismaiel, Inès Ben Ameur, Nahlah Al Srouji, Stefan-Lucian Popa, Simona Grad , Dilara Ensar, Dan L. Dumitrascu. Adiponectin Levels in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Digestive Diseases 2023; 41(6): 860 doi: 10.1159/000531614
|
| 16 |
Xin Xin Pang, Abdur Rahman Ansari, Wen Jie Yang, Xiao Yu Niu, Ling Dong, Hui Zhen Li, Fen Liang Xu, Zhe Wei Zhang, Ke Xiao, Song Hui. Visfatin Regulates Inflammatory Mediators in Mouse Intestinal Mucosa Through Toll-Like Receptors Signaling Under Lipopolysaccharide Stress. Archivum Immunologiae et Therapiae Experimentalis 2021; 69(1) doi: 10.1007/s00005-021-00611-y
|
| 17 |
Agata Michalak, Beata Kasztelan-Szczerbińska, Halina Cichoż-Lach. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A Review. Nutrients 2022; 14(19): 3983 doi: 10.3390/nu14193983
|
| 18 |
E Karaskova, V Kubickova, M Velganova-Veghova, M Geryk, H Foltenova, D Karasek. Circulating Levels of WISP-1 (Wnt1-Inducible Signaling Pathway Protein 1) and Other Selected Adipokines in Children With Inflammatory Bowel Disease. Physiological Research 2022; (2) doi: 10.33549/physiolres.934854
|
| 19 |
Anna Zielińska, Paweł Siwiński, Aleksandra Sobolewska-Włodarczyk, Maria Wiśniewska-Jarosińska, Jakub Fichna, Marcin Włodarczyk. The role of adipose tissue in the pathogenesis of Crohn’s disease. Pharmacological Reports 2019; 71(1): 105 doi: 10.1016/j.pharep.2018.09.011
|
| 20 |
Eva Karaskova, Maria Velganova-Veghova, Milos Geryk, Hana Foltenova, Veronika Kucerova, David Karasek. Role of Adipose Tissue in Inflammatory Bowel Disease. International Journal of Molecular Sciences 2021; 22(8): 4226 doi: 10.3390/ijms22084226
|
| 21 |
Arkadiusz Michalak, Paula Mosińska, Jakub Fichna. Common links between metabolic syndrome and inflammatory bowel disease: Current overview and future perspectives. Pharmacological Reports 2016; 68(4): 837 doi: 10.1016/j.pharep.2016.04.016
|
| 22 |
Roman M. Janas, Anna Rybak, Aldona Wierzbicka-Rucińska, Piotr Socha, Rafał Śnitko, Anna Szaflarska-Popławska, Anna Stolarczyk, Beata Oralewska, Elżbieta Cytra-Jarocka, Barbara Iwańczak, Urszula Grzybowska-Chlebowczyk, Wojciech Cichy, Grażyna Czaja-Bulsa, Jerzy Socha. Serum Concentrations of Insulin, Ghrelin, Adiponectin, Leptin, Leptin Receptor and Lipocalin-2 in Children with Celiac Disease Who Do and Do Not Adhere to a Gluten-Free Diet. Gut and Liver 2016; 10(4): 587 doi: 10.5009/gnl15404
|
| 23 |
A Tompa, K Åkesson, S Karlsson, M Faresjö. Suppressed immune profile in children with combined type 1 diabetes and celiac disease. Clinical and Experimental Immunology 2020; 201(3): 244 doi: 10.1111/cei.13454
|
| 24 |
Emanuel Fryk, Åsa Wilsson, Andrea Tompa, Per-Anders Jansson, Maria Faresjö. Galectin-1 correlates with inflammatory markers and T regulatory cells in children with type 1 diabetes and/or celiac disease. Clinical and Experimental Immunology 2024; 215(3): 240 doi: 10.1093/cei/uxad131
|
| 25 |
Belén Rivero-Gutiérrez, Carlos J. Aranda, Borja Ocón, María Arredondo, Olga Martínez-Augustin, Fermín Sánchez de Medina. Exogenous leptin reinforces intestinal barrier function and protects from colitis. Pharmacological Research 2019; 147: 104356 doi: 10.1016/j.phrs.2019.104356
|
| 26 |
Milos Geryk, Veronika Kucerova, Maria Velganova-Veghova, Hana Foltenova, Katerina Bouchalova, David Karasek, Martin Radvansky, Eva Karaskova. Association of selected adipokines with vitamin D deficiency in children with inflammatory bowel disease. BMC Pediatrics 2024; 24(1) doi: 10.1186/s12887-024-04890-0
|
| 27 |
Elizabeth A. Novak, Erin C. Crawford, Heather L. Mentrup, Brian D. Griffith, David M. Fletcher, Meredith R. Flanagan, Corinne Schneider, Brian Firek, Matthew B. Rogers, Michael J. Morowitz, Jon D. Piganelli, Qian Wang, Kevin P. Mollen. Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1231700
|
| 28 |
Wojciech Roczniak, Agnieszka Szymlak, Bogdan Mazur, Agata Chobot, Małgorzata Stojewska, Joanna Oświęcimska. Nutritional Status and Selected Adipokines in Children with Irritable Bowel Syndrome. Nutrients 2022; 14(24): 5282 doi: 10.3390/nu14245282
|
| 29 |
Nadia Sawicka-Gutaj, Bartłomiej Budny, Ariadna Zybek-Kocik, Jerzy Sowiński, Katarzyna Ziemnicka, Joanna Waligórska-Stachura, Marek Ruchała. Nicotinamide phosphoribosyltransferase leukocyte overexpression in Graves’ opthalmopathy. Endocrine 2016; 53(2): 497 doi: 10.1007/s12020-015-0855-8
|
| 30 |
Katarzyna Neubauer, Iwona Bednarz-Misa, Ewa Walecka-Zacharska, Jaroslaw Wierzbicki, Anil Agrawal, Andrzej Gamian, Malgorzata Krzystek-Korpacka. Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia. International Journal of Molecular Sciences 2019; 20(1): 166 doi: 10.3390/ijms20010166
|
| 31 |
Piotr Eder, Maciej Adler, Agnieszka Dobrowolska, Julian Kamhieh-Milz, Janusz Witowski. The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease. Cells 2019; 8(6): 628 doi: 10.3390/cells8060628
|
| 32 |
Yilin Wu, Jun Shen. Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies. Cytokine & Growth Factor Reviews 2024; 80: 156 doi: 10.1016/j.cytogfr.2024.10.003
|
| 33 |
P. Mosińska, D. Jacenik, M. Sałaga, A. Wasilewski, A. Cygankiewicz, A. Sibaev, A. Mokrowiecka, E. Małecka‐Panas, I. Pintelon, M. Storr, J. P. Timmermans, W. M. Krajewska, J. Fichna. FABP4 blocker attenuates colonic hypomotility and modulates white adipose tissue‐derived hormone levels in mouse models mimicking constipation‐predominant IBS. Neurogastroenterology & Motility 2018; 30(5) doi: 10.1111/nmo.13272
|
| 34 |
Elise Semerena, Alessio Nencioni, Krzysztof Masternak. Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1268756
|
| 35 |
Carolyne Falank, Heather Fairfield, Michaela R. Reagan. Signaling Interplay between Bone Marrow Adipose Tissue and Multiple Myeloma cells. Frontiers in Endocrinology 2016; 7 doi: 10.3389/fendo.2016.00067
|
| 36 |
Yi Kong, Suhan Zhang, Ruifang Wu, Xin Su, Daoquan Peng, Ming Zhao, Yuwen Su. New insights into different adipokines in linking the pathophysiology of obesity and psoriasis. Lipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1115-3
|
| 37 |
Efthymios P Tsounis, Ioanna Aggeletopoulou, Athanasia Mouzaki, Christos Triantos. Creeping Fat in the Pathogenesis of Crohn’s Disease: An Orchestrator or a Silent Bystander?. Inflammatory Bowel Diseases 2023; 29(11): 1826 doi: 10.1093/ibd/izad095
|
| 38 |
Fortunata Carbone, Claudia La Rocca, Paola De Candia, Claudio Procaccini, Alessandra Colamatteo, Teresa Micillo, Veronica De Rosa, Giuseppe Matarese. Metabolic control of immune tolerance in health and autoimmunity. Seminars in Immunology 2016; 28(5): 491 doi: 10.1016/j.smim.2016.09.006
|
| 39 |
Yun-Ha Lee, Hyeyoon Kim, Sorim Nam, Jae-Ryang Chu, Jung-Hwan Kim, Jong-Seok Lim, Sung-Eun Kim, Mi-Kyung Sung. Protective Effects of High-Fat Diet against Murine Colitis in Association with Leptin Signaling and Gut Microbiome. Life 2022; 12(7): 972 doi: 10.3390/life12070972
|
| 40 |
Paula Mosińska, Julia Krajewska. Introduction to Gastrointestinal Diseases Vol. 1. 2017; : 3 doi: 10.1007/978-3-319-49016-8_1
|
| 41 |
G. R. Bikbavova, M. A. Livzan, E. A. Shmurygina. Obesity and infl ammatory bowel disease: is there a link?. Experimental and Clinical Gastroenterology 2020; (10): 133 doi: 10.31146/1682-8658-ecg-182-10-133-141
|
| 42 |
Helen J. Dranse, Jillian L. Rourke, Andrew W. Stadnyk, Christopher J. Sinal. Local chemerin levels are positively associated with DSS-induced colitis but constitutive loss of CMKLR1 does not protect against development of colitis. Physiological Reports 2015; 3(8): e12497 doi: 10.14814/phy2.12497
|
| 43 |
Giorgia Colombo, Gian Paolo Caviglia, Alberto Ravera, Elisa Tribocco, Simone Frara, Chiara Rosso, Cristina Travelli, Armando A. Genazzani, Davide Giuseppe Ribaldone. NAMPT and NAPRT serum levels predict response to anti-TNF therapy in inflammatory bowel disease. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1116862
|
| 44 |
Feiyi Duan, Jiaoyan Wu, Jiayi Chang, Haoyuan Peng, Zitao Liu, Pengfei Liu, Xu Han, Tiantian Sun, Dandan Shang, Yutian Yang, Zhihao Li, Pengkun Li, Yixuan Liu, Yonghao Zhu, Yunzhi Lv, Xiumei Guo, Ying Zhao, Yang An. Deciphering endocrine function of adipose tissue and its significant influences in obesity-related diseases caused by its dysfunction. Differentiation 2025; 141: 100832 doi: 10.1016/j.diff.2024.100832
|
| 45 |
Yu. P. Uspenskiy, S. V. Ivanov, O. V. Mayorova, J. A. Fominykh. Inflammatory bowel disease and obesity: current state of issue. Medical alphabet 2021; (37): 29 doi: 10.33667/2078-5631-2020-37-29-34
|
| 46 |
Serkan Dogan, Kadri Guven, Mehmet Celikbilek, Kemal Deniz, Berkay Saraymen, Sebnem Gursoy. Serum Visfatin Levels in Ulcerative Colitis. Journal of Clinical Laboratory Analysis 2016; 30(5): 552 doi: 10.1002/jcla.21901
|
| 47 |
Simcha Weissman, Kirtenkumar Patel, Sindhura Kolli, Megan Lipcsey, Nabeel Qureshi, Sameh Elias, Aaron Walfish, Arun Swaminath, Joseph D Feuerstein. Obesity in Inflammatory Bowel Disease Is Associated with Early Readmissions Characterised by an Increased Systems and Patient-level Burden. Journal of Crohn's and Colitis 2021; 15(11): 1807 doi: 10.1093/ecco-jcc/jjab088
|
| 48 |
Jason W Harper, Timothy L Zisman. Interaction of obesity and inflammatory bowel disease. World Journal of Gastroenterology 2016; 22(35): 7868-7881 doi: 10.3748/wjg.v22.i35.7868
|
| 49 |
Yu-Ju Peng, Tang-Long Shen, Yu-Shan Chen, Harry John Mersmann, Bing-Hsien Liu, Shih-Torng Ding. Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease. Journal of Biomedical Science 2018; 25(1) doi: 10.1186/s12929-018-0419-3
|
| 50 |
Ying Zheng, Junlong Lin, Siqi Zhou, Shanying Liao, Yiming Fu, Yanjun Zhang, Xinbin Chen, Jinghong Li, Weihong Sha, Shixue Dai, Wenjun Ma. Circulating leptin levels in the assessment of Crohn’s disease activity and its relation to nutritional status. Nutrición Hospitalaria 2023; doi: 10.20960/nh.04572
|
| 51 |
Chieh Chen. The role of adipokines in the disease of metabolic-associated fatty liver disease. Tungs' Medical Journal 2023; 17(2): 49 doi: 10.4103/ETMJ.ETMJ-D-23-00015
|
| 52 |
Yuko Akazawa, Tomohito Morisaki, Hiroko Fukuda, Kiyuu Norimatsu, Junya Shiota, Keiichi Hashiguchi, Maiko Tabuchi, Moto Kitayama, Kayoko Matsushima, Naoyuki Yamaguchi, Hisayoshi Kondo, Fumihiko Fujita, Hiroaki Takeshita, Kazuhiko Nakao, Fuminao Takeshima. Significance of serum palmitoleic acid levels in inflammatory bowel disease. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-95923-6
|
| 53 |
Jun Luo, Hong ping Li, Fen Xu, Ben qing Wu, Hung Chih Lin. Early diagnosis of necrotizing enterocolitis by plasma RELMβ and thrombocytopenia in preterm infants: A pilot study. Pediatrics & Neonatology 2019; 60(4): 447 doi: 10.1016/j.pedneo.2019.01.006
|
| 54 |
Gerardo Calderón, Andrés Acosta. Dietary Interventions in Gastrointestinal Diseases. 2019; : 43 doi: 10.1016/B978-0-12-814468-8.00004-1
|
| 55 |
Amir Hossein Behnoush, Seyede Parmis Maroufi, Tara Reshadmanesh, Yasmin Mohtasham Kia, Mitra Norouzi, Seyedeh Mina Mohammadi, Aleksandra Klisic, Amirmohammad Khalaji. Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03199-7
|
| 56 |
Joan Tosca, Natalia Garcia, Isabel Pascual, Marta Maia Bosca-Watts, Rosario Anton, Ana Sanahuja, Pilar Mas, Francisco Mora, Miguel Minguez. Clinical assessment of risk factors for infection in inflammatory bowel disease patients. International Journal of Colorectal Disease 2020; 35(3): 491 doi: 10.1007/s00384-019-03501-0
|
| 57 |
Jan Bilski, Agnieszka Mazur-Bialy, Dagmara Wojcik, Marcin Surmiak, Marcin Magierowski, Zbigniew Sliwowski, Robert Pajdo, Slawomir Kwiecien, Aleksandra Danielak, Agata Ptak-Belowska, Thomas Brzozowski. Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases. Biomolecules 2019; 9(12): 780 doi: 10.3390/biom9120780
|
| 58 |
Roxane Kreuter, Miriam Wankell, Golo Ahlenstiel, Lionel Hebbard. The role of obesity in inflammatory bowel disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(1): 63 doi: 10.1016/j.bbadis.2018.10.020
|